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Summary 
Sister chromatid cohesion, which depends on cohesin, is essential for the faithful 
segregation of replicated chromosomes. Here, we report that splicing complex Prp19 
is essential for cohesion in both G2 and mitosis, and consequently for the proper 
progression of the cell through mitosis. Inactivation of splicing factors SF3a120 and 
U2AF65 induces similar cohesion defects to Prp19 complex inactivation. Our data 
indicate that these splicing factors are all required for the accumulation of cohesion 
factor sororin, by facilitating the proper splicing of its pre-mRNA. Finally, we show 
that ectopic expression of sororin corrects defective cohesion caused by Prp19 
complex inactivation. We propose that the Prp19 complex and the splicing machinery 
contribute to the establishment of cohesion by promoting sororin accumulation during 




In eukaryotes, sister chromatid cohesion (SCC) is essential for faithful transmission 
of the replicated genome between generations and depends on cohesin (Guacci et 
al., 1997; Losada et al., 1998; Michaelis et al., 1997). In vertebrates, cohesin is 
composed of the core subunits Smc1, Smc3, Scc1 and SA1 or SA2 (Losada et al., 
2000; Sumara et al., 2000), and the regulatory proteins Pds5A or Pds5B (Gandhi et 
al., 2006; Kueng et al., 2006; Losada et al., 2005; Schmitz et al., 2007; Sumara et al., 
2000), Wapl (Gandhi et al., 2006; Kueng et al.) and sororin (Rankin et al., 2005). 
Establishment of SCC in S phase requires acetylation of Smc3 by Esco1 and Esco2 
on two lysine residues at positions 105 and 106 in humans (Nishiyama et al., 2010; 
Rolef Ben-Shahar et al., 2008; Unal et al., 2008; Zhang et al., 2008). As cells 
progress in S phase, newly synthesised sororin binds to acetylated Smc3, 
counteracts the anti-cohesive property of Wapl and promotes SCC establishment 
(Nishiyama et al., 2010; Ouyang et al., 2013 ).  
The Prp19 complex is composed of four core proteins: Prp19, Cdc5L, Plrg1 and 
Spf27/BCAS2, and of three associated proteins CTNNBL1, AD002 and HSP73 (Ajuh 
et al., 2000; Grote et al., 2010). Prp19 complex functions in pre-mRNA splicing 
(Cheng et al., 1993; Tarn et al., 1993), in DNA damage response (Zhang et al., 2009) 
and in transcription elongation (Chanarat et al., 2011). Inactivation of Prp19 complex 
by RNAi causes cell’s arrest in prometaphase with misaligned chromosomes 
(Hofmann et al., ; Neumann et al., 2010), similar to cellular consequences of SCC 
deficiency. Furthermore, Prp19 complex and cohesin were described as being part of 
a large and evolutionarily conserved protein complex (McCracken et al., 2005). 
Based on these observations, we hypothesised that Prp19 complex may be involved 
in the regulation of SCC in human. 
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Results and Discussion 
Prp19 complex is required for sister chromatid cohesion in mitosis  
To address whether Prp19 complex functions in SCC, we investigated consequences 
of depleting Prp19 complex core components on mitotic SCC and on progression 
through mitosis in HeLa cells. To assess phenotype specificity, we used a HeLa cell 
line that constitutively expresses murine Cdc5L fused to a localisation-and-affinity-
purification (LAP) tag containing green fluorescent protein (GFP) (Figure E1A-B,D) 
and resistant to hCdc5L siRNAs (Figures 1D and E1C). Cells were transfected with 
control, Scc1, Cdc5L or Prp19 small interfering RNAs (siRNAs) and we analysed 
SCC status in mitoses 24, 48 and 72 hours later, by observation of spread 
chromosomes (Figure 1A). In both cell lines, most of control cells displayed normal 
cohesion when a separation of sister chromatids 72 hours after transfection was 
observed in up to 90 % of cells depleted of Cdc5L or Prp19, similar to depletion of 
cohesin itself (Figure 1B, C). Consistently, most of mCdc5L-LAP cells depleted of 
Scc1 and Prp19 displayed cohesion defects (Figure 1C). By contrast, Cdc5L 
depletion had almost no effect on SCC in these cells, demonstrating that reduced 
level of endogenous Cdc5L protein caused SCC defects. Western blot analyses 
revealed that total amounts of Prp19 and Cdc5L were reduced respectively in Cdc5L 
and in Prp19 depleted cells (Figure 1D), possibly because one becomes unstable in 
the absence of the other. Consistent with the cohesion defects in mitosis, inactivation 
of Prp19 complex resulted in an arrest in prometaphase, with the chromosomes 
failing to align on the metaphase plate (Figure E1E-G). Importantly, in these cells 
enrichment of the centromeric region in the chromosome passenger protein Aurora B 
was maintained (Figure 1E), demonstrating that cohesion loss was not due to an 
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untimely cell’s entry into anaphase. Thus, the depletion of either Cdc5L or Prp19 
leads to the premature separation of sister chromatids implying that Prp19 complex is 
required for normal SCC in mitosis. We also noticed that Cdc5L and Prp19 depleted 
cells displayed aberrant, collapsed mitotic spindles (Figure E1E and F) that were 
more pronounced in Cdc5L than in Prp19 depleted cells, presumably because of 
differences in depletion efficiency. The appearance of these abnormal spindles is 
unlikely to be an indirect consequence of defective SCC, as this was not observed in 
Scc1 depleted cells. Rather, it could indicate a distinct and specific role of Prp19 
complex in mitotic spindle assembly, as reported recently (Hofmann et al., 2013). 
 
Prp19 complex is required for accumulation of sororin protein through splicing 
of sororin pre-mRNA and for interphase cohesion 
As Prp19 complex functions in pre-mRNA splicing, its inactivation may affect splicing 
of pre-mRNA(s) encoding protein(s) essential to SCC and thus induce cohesion 
defects in an indirect manner. Consistent with this possibility we observed that 
depletion of two splicing factors distinct from Prp19 complex, SF3A120 and U2AF65 
(Hoffman and Grabowski, 1992; Tanackovic and Kramer, 2005), as well as chemical 
inhibition of splicing using spliceostatin A (SSA, Kaida et al., 2007) also triggered 
defective mitotic cohesion (Figure 2A-B). These treatments also increased mitotic 
indices, except for SF3A120 depletion where only few cells were in mitosis possibly 
because additional role of SF3A120 (Figure 2C). This indicates that SCC defects are 
common early consequence of splicing deficiency, and suggests that Prp19 complex 
involvement in SCC is an indirect consequence of its function in splicing. If true, 
Prp19 complex inactivation should then affect the production of protein(s) required for 
normal cohesion. To test this possibility we analysed cellular levels of known proteins 
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involved in cohesion after Prp19 complex inactivation. HeLa cells treated with control, 
Cdc5L or Prp19 siRNAs were synchronised at the G1/S transition by double 
thymidine arrest. Before the second release and 4 hours later, total protein extracts 
were prepared and analysed by western blotting experiments (Figure 3A). In control 
cells, level of sororin, which is essential to SCC (Rankin et al., 2005; Schmitz et al., 
2007), increased during the course of the experiment, consistent with its 
accumulation during S phase (Nishiyama et al., 2010), and similar to the 
accumulation of its mRNA during this period (Figure E2C). By contrast, sororin 
accumulation was greatly reduced in cells where Cdc5L and Prp19 were depleted 
(Figure 3A and E2A), when level of other known interphase cohesion factors was 
unaffected (Figure E2B). Similarly, reduced accumulation of sororin was also 
observed upon SF3a120 or U2AF65 depletion and SSA treatment (Figure 3B). These 
results indicate that splicing inactivation leads to reduced accumulation of sororin, 
possibly by perturbing the splicing of its pre-mRNA. Consistent with this possibility, 
increased retention of sororin RNA introns 1 and 2, as well as to a lesser extent that 
of intron 5 of GUSB RNA used as a control, could be observed in Prp19 and Cdc5L 
depleted cells when compared to control cells (Figure 3C). By contrast, no particular 
increased intron retention in Smc1, Smc3, Scc1, SA1, SA2, Esco1 and Esco2 could 
be observed (Figure E3D), indicating that sororin splicing was selectively affected by 
Prp19 complex inactivation. Similar observations were also made upon SF3a120 or 
U2AF65 depletion and SSA treatment (Figure 3D and E2F), although SSA had a 
stronger overall impact on RNA splicing. This indicates that Prp19 complex and 
spliceosome inactivation leads to accumulation of unspliced sororin pre-mRNA, and 
demonstrates that Prp19 complex is essential for the accumulation of sororin protein 
as a consequence of its function in splicing. This also suggest that the described 
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interaction between Prp19 complex and cohesin (McCracken et al., 2005), known to 
act in gene expression, could reflect a common function of these complexes in 
transcription regulation, RNA maturation, or in the coupling between these two 
processes. 
Sororin is a protein conserved from fly to human that is degraded as cells exit from 
mitosis (Rankin and Kirschner, 2005) and accumulates during S phase (Nishiyama et 
al., 2010). If sororin reduction accounts for cohesion defects observed upon Prp19 
complex inactivation, then this inactivation should produce phenotypes similar to 
those of sororin depletion. Consistent with this prediction, we observed that cohesin 
complexes were still associated with chromatin upon Cdc5L depletion (Figure E3E) 
indicating that Prp19 complex, similar to sororin (Schmitz et al., 2007), is dispensable 
for the association of cohesin with chromatin. Next we assessed interphase SCC by 
DNA fluorescence in situ hybridisation (FISH) using a probe recognising a region that 
is trisomic in HeLa cells (Figure 3E)(Schmitz et al., 2007; Watrin and Peters, 2006). 
We addressed cohesion status in cells depleted of Cdc5L, Prp19 or Scc1 by 
measuring distances between paired dots (Figure 3F). In control cells, the mean 
distance between paired FISH signals was 0.4 µm and increased to 0.67 µm in Scc1 
depleted cells, and to 0.64 µm and 0.65 µm in Cdc5L and Prp19 depleted cells, 
respectively. Thus, similar to sororin, Prp19 complex is dispensable for cohesin 
loading onto chromatin and is required for interphase cohesion.  
 
Correction of endogenous sororin protein level counteracts SCC deficiency 
caused by Prp19 complex inactivation 
These observations altogether strongly suggest that reduction in sororin protein 
accounts for defective cohesion caused by Prp19 inactivation. This implies that 
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correcting sororin protein level should rescue the cohesion defects caused by Prp19 
complex inactivation. To test this prediction directly we generated an intron-free 
sororin coding sequence, expression of which in cells does not depend on splicing. 
We used this sequence to establish a cell line expressing sororin in fusion with GFP 
(sororin-GFP), which is expressed at a level close to that of endogenous sororin, and 
is resistant to siRNAs (Figure 4A). Both cell lines were treated with control, sororin, 
Scc1, Cdc5L and Prp19 siRNAs, and mitotic chromosome spreads were prepared 
and analysed at different times after transfection. As shown in Figure 4B, the 
proportion of wildtype cells exhibiting defective cohesion upon sororin depletion 
reached 84 % 48 hours after siRNA transfection. In sororin-GFP cells, this number 
was reduced to 44 %, indicating that sororin-GFP compensates partially for 
endogenous sororin depletion. This incomplete rescue might be due to uneven 
expression levels between cells or to sororin not being fully functional when tagged 
with GFP. By contrast, the expression of sororin-GFP had no effect on defective 
cohesion observed after Scc1 depletion (Figure 4B, upper panel) indicating that 
sororin-GFP only rescues cohesion defects caused by reduced sororin level. Finally, 
proportions of cells exhibiting defective cohesion upon Cdc5L and Prp19 depletion 
reached 84 % and 68 % respectively in wildtype cells, and decreased to 51 % and 
46 % in sororin-GFP cells (Figure 4B, lower panel). These results indicate that 
expression of sororin-GFP is sufficient to rescue Cdc5L and Prp19 depletions, at 
least partly. This strongly supports the possibility that defective cohesion caused by 
inactivation of Prp19 complex directly originated from reduced level of sororin protein, 
although we cannot rule out that reduced level of another, as yet unidentified, 
cohesion factor could also participate in this phenotype. We also observed that, even 
though ectopic expression of sororin was able to correct defective SCC caused by 
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Prp19 complex inactivation, most mitotic cells in which cohesion had been restored 
still displayed abnormal spindles (unpublished observation, EW). Consequently, 
number of mitotic cells was similarly high in both cell lines upon Prp19 complex 
inactivation (Figure 4C). This indicates that sororin reduction, and therefore defective 
cohesion, is not the sole consequence of Prp19 complex inactivation, and suggests 
that Prp19 complex, or spliceosome activity, also impacts on proper assembly of 
mitotic spindle, in agreement with previous report (Hofmann et al., 2013). This 
observation also illustrates pleitropic involvements of spliceosome in cell’s 
progression though mitosis. 
Finally, we took advantage of the anti-cohesive property of the protein Wapl. RNAi-
mediated depletion of Wapl is able to rescue defective cohesion caused by sororin 
depletion (Nishiyama et al., 2010). Thus, if defective cohesion observed upon 
inactivation of Prp19 complex was caused by a reduction in sororin level, depleting 
Wapl at the same time should then restore normal SCC. To test this prediction, cells 
treated with control, sororin, Cdc5L and Prp19 siRNAs were eventually depleted of 
Wapl by RNAi (Figure 4D), and SCC was assessed by chromosome spreading. As 
shown before (Kueng et al., 2006), Wapl depletion prevented opening of 
chromosome arms in more than 80 % of prometaphase cells. Furthermore, the 
proportion of prometaphase cells exhibiting uncohered sister chromatid upon sororin 
depletion was reduced from 90 % to 12 % by the co-depletion of Wapl, as previously 
reported (Nishiyama et al., 2010). Finally, Wapl depletion was also able to rescue 
cohesion defects caused by Cd5L and Prp19 depletions, further supporting the 
notion that cohesion defects originated from reduced level of sororin. Altogether 
these results indicate that reduced expression of sororin consequent to defective 
splicing of its pre-mRNA accounts for defective cohesion upon Prp19 complex 
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inactivation. Why would sororin pre-mRNA be so sensitive to splicing inactivation? In 
contrast to other known interphase cohesion factors, present at similar cellular level 
throughout the cell cycle, sororin is degraded at every cell’s exit from mitosis. Hence, 
robust SCC relies on de novo production of sororin proteins during S phase, and 
would thus be particularly sensitive to defective processing of sororin pre-mRNA, as 
compared to that of pre-mRNAs encoding other cohesion factors. In addition, we 
showed that splicing of sororin was more sensitive to spliceosome inactivation than 
any other well established interphase cohesion factors, although the molecular basis 
for this difference remains to be determined. 
Interestingly, genome-wide RNAi studies have shown that depletion of 30 distinct 
splicing factors, including factors studied here, resulted in perturbed mitosis 
(Hofmann et al., 2010; Neumann et al., 2010), consistent with defective SCC. Mark 
Petronczki and his collaborators made the striking discovery that depletion of any of 
these 30 splicing factors resulted in defective cohesion in mitosis (personal 
communication), identical to results we reported here, indicating that inactivation of 
various splicing factors causes remarkably similar SCC defects and strongly 
suggesting that defective cohesion, possibly due to reduced level of sororin, is a 
common feature of altered splicing machinery. Mutations in SCC apparatus genes 
are associated with cancers, including myeloid neoplasms (Kon et al., 2013), bladder 
cancer (Balbas-Martinez et al., 2013), glioblastoma, melanoma and Ewing’s sarcoma 
(Solomon et al., 2011) and trigger aneuploidy and chromosome instability in 
glioblastoma cells (Solomon et al., 2011). Recent work has suggested that 
acquisition of mutations in SCC components is an important step in oncogenic 
process (Yoshida et al., 2013). Similarly, mutations in genes encoding splicing factors 
are also found in cancers such as myeloid neoplasmic disorders (Yoshida et al., 
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2011) and chronic lymphocytic leukaemia (Ebert and Bernard, 2011). Based on our 
findings that perturbation of the splicing machinery alters cohesin and SCC 
regulation, it is possible that deleterious mutations in splicing genes participate in 
oncogenesis by promoting genome instability though defective cohesin functions, at 
least in some cancer types. Further molecular investigations in different cancers will 
be essential to determine if and how splicing machinery deficiencies participate in 
tumorisation through defective cohesion. 
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Experimental procedures 
RNA extraction, reverse transcription, PCR and quantitative PCR analyses 
Total RNAs were extracted from HeLa cells using the RNeasy kit (Qiagen). 1 µg of 
total RNAs served as matrix in reverse transcription reaction using Superscript II 
reverse transcriptase (Life Technologies). PCR reactions were performed using 
primer pairs that specifically span from exon 2 to exon 3 of p80-coilin pre-mRNA or 
amplify the junction between exon 3 (e3) and intron 3 (i3) of β-actin pre-mRNA 
(sequences were described in (Kaida et al., 2007; Tanackovic and Kramer, 2005), 
respectively). PCR products were analysed by electrophoresis on 1 % agarose gel. 
Quantitative real time PCR analyses were performed using Power-Sybr mix on a 
7700 QPCR ABI following the manufacturer’s instructions with primers shown in 
Table E1. For intron retention, the relative abundance of pre-mRNA over total RNA 
(pre-mRNA+mRNA) was calculated as follows: -ΔCt = -(Ctpre-mRNA − Cttotal RNA). The 
relative abundance of total RNAs was calculated as: -ΔCt = -(Ctexon − CtexonGUSB). All 
measures were done in triplicates. Intron-spanning primer pairs were used for mature 
mRNAs, primers amplifying exon-intron or intron-exon junctions were used for pre-
mRNAs, and pairs within one exon were used for total RNAs (Table E1). 
 
Cell culture, synchronisation and RNAi 
HeLa cells were grown in DMEM (Invitrogen) supplemented with 10 % foetal bovine 
serum (PAA), 0.2 mM L-glutamine and antibiotics (Invitrogen). Single mCdc5L-LAP 
cell clones were isolated from an mCdc5L-LAP cell pool, selected in medium 
containing 800 µg/ml geneticin (PAA) and maintained in medium supplemented with 
400 µg/ml geneticin. Sororin-GFP cell lines were obtained by transfection and 
subsequent selection with 800 µg/ml of geneticin (Invitrogen) and were maintained in 
 13 
the presence of 200 µg/ml of geneticin. For double-thymidine arrest synchronisation 
procedure, cells were treated for 24 hours with 2 mM thymidine, washed twice with 
37°C PBS and released in fresh complete medium. 6 hours later, thymidine was 
added for 18 hours. Synthetic siRNA oligonucleotides were purchased from Ambion 
and Eurogentec, and were used at a final concentration of 100 nM to transfect cells 
in the presence of Jetprime (PolyPlus Transfection). The sequences of the control, 
Scc1, Wapl and sororin siRNAs used here have been described elsewhere (Kueng et 
al., 2006; Schmitz et al., 2007; Watrin et al., 2006). The sequences of Cdc5L, Prp19 
and SF3a120 have also been described in previous studies (Liu et al., 2009; 
Tanackovic and Kramer, 2005). Sequence of U2AF65 siRNA used in this study was: 
5’-AAGGUCCGUAAAU-ACUGGGACdTdT-3’. Cells were used at the indicated times 
after transfection. The small inhibitor spliceostatin A was kindly provided by Minoru 
Yoshida (Kaida et al., 2007). 
 
Immunofluorescence and chromosome spreads 
Immunofluorescence staining, was performed as previously described (Watrin and 
Legagneux, 2005). Immunofluorescence analyses were performed using a 
fluorescent microscope (DMRXA2 Leica) with a 40x oil immersion objective lens, and 
images were processed using MetaMorph software (Molecular Devices). For 
chromosome spread, cells were treated for 30 minutes with 100 ng/mL of 
nocodazole. Cells were collected and resuspended in 1 mL of medium, 1.5 mL of tap 
water was added. 6 minutes later 7 mL of Carnoy fixative (3:1, methanol: glacial 
acetic acid). Cells were then spreads on glass slide, dried, stained with Giemsa stain 
and mounted in Entellan. Mitotic chromosome spreads observations were made 
using a light microscope (DM2000 Leica) with a 40x dry objective. 
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Expanded view inventory 
Figure E1. Additional materials in support to Figure 1. 
Figure E2. Additional materials in support to Figure 3. 
Table E1. List of primers used in real-time quantitative PCR, related to Figure 3. 
Expanded view figure legends. 
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Figure legends 
Figure 1. Depletion of either Cdc5L or Prp19 causes precocious sister chromatid 
separation in mitosis and arrests cells in a prometaphase-like state. 
(A-D) Wildtype and mCdc5L-LAP HeLa cells were transfected with control, Scc1, 
Cdc5L and Prp19 siRNAs and chromosome spreads were prepared 24, 48 and 72 
hours after transfection. (A) Representative images of chromosome spreads. The 
percentages of phenotypes for wildtype and for mCdc5L-LAP HeLa prometaphase 
cells are shown in (B) and (C), respectively (n > 100 per condition). (D) Depletion 
efficiency was analysed by immunoblotting with the antibodies indicated 72 hours 
after transfection. 
(E) Aurora B remains at the centromere in Cdc5L, Prp19 or Scc1 depleted cells. Cells 
transfected as in (A) were fixed and stained with human CREST serum (red) and 
Aurora B antibody (green). DNA (blue) was stained with DAPI. 
 
Figure 2. Depletion of the splicing factors SF3a120 and U2AF65 or chemical 
inhibition of the splicing machinery cause premature separation of sister chromatids 
in mitosis. 
(A-B) HeLa cells were transfected with control and SF3a120 (A) or U2AF65 (B) 
siRNAs, and chromosome spreads were prepared 24 and 48 hours after transfection. 
Percentages of prometaphase cells displaying defective cohesion were determined 
(middle panels, n > 100 per condition). Depletion efficiency was analysed by 
immunoblotting with the antibodies indicated (left panels). Percentages of 
prometaphase cells in each condition are shown in right panels. 
(C) HeLa cells were treated with 5 nM of SSA or with methanol for 24 hours. RT-PCR 
reaction were performed to detect intron retention in p80-coilin and β-actin pre-
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mRNAs and analysed on agarose gel (left panels). In parallel, cells were left 
untreated or treated for 24 hours with methanol, 0.5 or 2 nM of SSA and processed 
as in (A). Percentages of prometaphase cells displaying defective cohesion are 
shown (middle panel, n > 100 per condition), and percentages of prometaphase cells 
are shown in right panel. 
 
Figure 3. Inactivation of Prp19 complex impairs sororin protein accumulation and 
triggers defective cohesion in postreplicative interphase cells. 
(A) HeLa cells were transfected with control, Cdc5L (left panel) or Prp19 (right panel) 
siRNAs and synchronised by double thymidine block procedure. 72 hours after 
transfection, total cell extracts were prepared before (0 h) or 4 hours after the second 
release (4 h) and analysed by immunoblotting using the antibodies indicated. 
(B) HeLa cells were transfected with control, SF3a120 (left panel) or U2AF65 (middle 
panel) siRNAs and synchronised by double thymidine block procedure. 72 hours after 
transfection, total cell extracts were prepared and analysed as in (A). Synchronised 
cells treated for 24 hours with spliceostatin A were collected before (0 h) or 4 hours 
following the second release (4h), and were analysed as in (A) (right panel). 
 (C) Total RNAs were extracted from control, Cdc5L and Prp19 depleted cells, and 
real-time quantitative PCR experiments were performed to determine the 
abundances of pre-mRNA for sororin and for GUSB (used as a control) in the 
different RNAi conditions. Results are expressed as -ΔCt (log scale) relative to those 
obtained for total RNA using primer pairs specific for sororin exon 5 and GUSB exon 
7. Results of four independent experiments are presented (mean ± SEM). 
 (D) Total RNAs were extracted from control, SF3A120, U2AF65 depleted and cells 
treated with SSA, and the abundances of pre-mRNA for sororin and for GUSB were 
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analysed as in (C). Results of three independent experiments are presented (mean ± 
SEM). 
(E-F) DNA FISH of control, Scc1, Cdc5L and Prp19 depleted G2 cells. (E) 
Representative images of DAPI-stained nuclei (blue) with paired FISH signals (red) 
are shown. Insets show magnified images of single FISH signal pairs. (F) 
Quantification of distances between paired FISH signals obtained in the experiment 
described in (E) (mean ± SD; n ≥ 30 per condition). Asterisks indicate a significant 
difference to the control in Student’s t test (p < 0.01). 
 
Figure 4. Ectopic correction of sororin protein level and depletion of Wapl rescue 
cohesion deficiency caused by Prp19 complex inactivation. 
(A) Wildtype and sororin-GFP HeLa cells were transfected with control and sororin 
siRNAs. 48 hours after transfection, total cell extracts were prepared and analysed by 
immunoblotting experiments using the antibodies indicated. 
(B-C) Wildtype and sororin-GFP HeLa cells were transfected with control, Sororin, 
Scc1, Cdc5L and Prpr19 siRNAs. At the indicated time after transfection, 
chromosome spreads were prepared as described. Percentages of prometaphase 
cells displaying defective cohesion as defined in Figure 1 are shown in panel (B) (n > 
100 per condition), and corresponding mitotic indices are shown in (C) (n > 300 per 
condition). 
 (D) HeLa cells transfected (+) or not (-) with Wapl siRNAs were also transfected with 
control, sororin, Cdc5L and Prp19 siRNAs, and mitotic chromosome spreads were 
prepared 48 and 72 hours later. Percentages of prometaphase cells that exhibit close 
or open chromosome conformation (normal cohesion) and defective cohesion, as 
defined in Figure 1A, are shown (n > 100 per condition).   
 22 
 
 




